411 related articles for article (PubMed ID: 21451458)
1. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.
Holtkamp FA; de Zeeuw D; Thomas MC; Cooper ME; de Graeff PA; Hillege HJ; Parving HH; Brenner BM; Shahinfar S; Lambers Heerspink HJ
Kidney Int; 2011 Aug; 80(3):282-7. PubMed ID: 21451458
[TBL] [Abstract][Full Text] [Related]
2. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.
Miao Y; Ottenbros SA; Laverman GD; Brenner BM; Cooper ME; Parving HH; Grobbee DE; Shahinfar S; de Zeeuw D; Lambers Heerspink HJ
Hypertension; 2011 Jul; 58(1):2-7. PubMed ID: 21632472
[TBL] [Abstract][Full Text] [Related]
3. Have we observed the implications of the acute fall in eGFR during treatment with losartan?
Ring T
Kidney Int; 2012 Mar; 81(6):595-6; author reply 597. PubMed ID: 22373703
[No Abstract] [Full Text] [Related]
4. Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success?
Weir MR
Kidney Int; 2011 Aug; 80(3):235-7. PubMed ID: 21760601
[TBL] [Abstract][Full Text] [Related]
5. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
Lambers Heerspink HJ; Weldegiorgis M; Inker LA; Gansevoort R; Parving HH; Dwyer JP; Mondal H; Coresh J; Greene T; Levey AS; de Zeeuw D
Am J Kidney Dis; 2014 Feb; 63(2):244-50. PubMed ID: 24210590
[TBL] [Abstract][Full Text] [Related]
6. Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
Weldegiorgis M; de Zeeuw D; Dwyer JP; Mol P; Heerspink HJL
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1595-1600. PubMed ID: 28923834
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic tradeoff between the adverse impacts of a lower GFR and long-term renal protection.
Adam WR
Kidney Int; 2012 Feb; 81(3):323-4. PubMed ID: 22241563
[No Abstract] [Full Text] [Related]
8. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
[TBL] [Abstract][Full Text] [Related]
9. Annual deterioration of renal function in hypertensive patients with and without diabetes.
Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
[TBL] [Abstract][Full Text] [Related]
10. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
Fried LF; Duckworth W; Zhang JH; O'Connor T; Brophy M; Emanuele N; Huang GD; McCullough PA; Palevsky PM; Seliger S; Warren SR; Peduzzi P;
Clin J Am Soc Nephrol; 2009 Feb; 4(2):361-8. PubMed ID: 19118120
[TBL] [Abstract][Full Text] [Related]
11. A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function.
Apperloo AJ; de Zeeuw D; de Jong PE
Kidney Int; 1997 Mar; 51(3):793-7. PubMed ID: 9067912
[TBL] [Abstract][Full Text] [Related]
12. Pre-renal success.
Hirsch S
Kidney Int; 2012 Mar; 81(6):596; author reply 597. PubMed ID: 22373705
[No Abstract] [Full Text] [Related]
13. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Schjoedt KJ; Andersen S; Rossing P; Tarnow L; Parving HH
Diabetologia; 2004 Nov; 47(11):1936-9. PubMed ID: 15551047
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
[TBL] [Abstract][Full Text] [Related]
15. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
16. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
Diabetes Care; 2003 May; 26(5):1501-6. PubMed ID: 12716812
[TBL] [Abstract][Full Text] [Related]
17. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
Issa N; Ortiz F; Reule SA; Kukla A; Kasiske BL; Mauer M; Jackson S; Matas AJ; Ibrahim HN; Najafian B
Kidney Int; 2014 Feb; 85(2):404-15. PubMed ID: 23965522
[TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study.
Kurokawa K; Chan JC; Cooper ME; Keane WF; Shahinfar S; Zhang Z
Clin Exp Nephrol; 2006 Sep; 10(3):193-200. PubMed ID: 17009077
[TBL] [Abstract][Full Text] [Related]
19. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate.
Dragović T; Ajdinović B; Hrvacević R; Ilić V; Magić Z; Andelković Z; Kocev N
Vojnosanit Pregl; 2010 Apr; 67(4):273-8. PubMed ID: 20465154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
